These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31915596)

  • 41. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful radiofrequency ablation strategies for benign thyroid nodules.
    Lee GM; You JY; Kim HY; Chai YJ; Kim HK; Dionigi G; Tufano RP
    Endocrine; 2019 May; 64(2):316-321. PubMed ID: 30569260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sonography-guided percutaneous microwave ablation of intrahepatic primary cholangiocarcinoma.
    Yu MA; Liang P; Yu XL; Cheng ZG; Han ZY; Liu FY; Yu J
    Eur J Radiol; 2011 Nov; 80(2):548-52. PubMed ID: 21300500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of long-term therapeutic effects of ultrasound-guided percutaneous microwave ablation of liver metastases].
    Liang P; Dong BW; Yu XL; Yu DJ; Feng L; Gao YY; Wang Y; Xiao QJ
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):806-10. PubMed ID: 16681966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma.
    Zhang K; Yu J; Yu X; Han Z; Cheng Z; Liu F; Liang P
    Int J Hyperthermia; 2018 May; 34(3):292-297. PubMed ID: 28540822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.
    Lee KF; Wong J; Hui JW; Cheung YS; Chong CC; Fong AK; Yu SC; Lai PB
    Asian J Surg; 2017 Jul; 40(4):301-308. PubMed ID: 26922631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. US-Guided Percutaneous Radiofrequency versus Microwave Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study.
    Cheng Z; Che Y; Yu S; Wang S; Teng D; Xu H; Li J; Sun D; Han Z; Liang P
    Sci Rep; 2017 Aug; 7(1):9554. PubMed ID: 28842651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereotactic radiofrequency ablation.
    Bale R; Widmann G; Haidu M
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):852-6. PubMed ID: 20734193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods?
    Korkusuz Y; Gröner D; Raczynski N; Relin O; Kingeter Y; Grünwald F; Happel C
    Eur Radiol; 2018 Mar; 28(3):929-935. PubMed ID: 28894936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
    Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
    Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.
    Lu MD; Xu HX; Xie XY; Yin XY; Chen JW; Kuang M; Xu ZF; Liu GJ; Zheng YL
    J Gastroenterol; 2005 Nov; 40(11):1054-60. PubMed ID: 16322950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United States, 2004-2015: an NCDB analysis.
    Kolarich AR; Shah JL; George TJ; Hughes SJ; Shaw CM; Geller BS; Grajo JR
    J Gastrointest Oncol; 2018 Jun; 9(3):536-545. PubMed ID: 29998019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous ablation of the tumor feeding artery for hypervascular hepatocellular carcinoma before tumor ablation.
    Zhang ZY; Lee JC; Yang W; Yan K; Wu W; Wang YJ; Chen MH
    Int J Hyperthermia; 2018; 35(1):133-139. PubMed ID: 29999436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: analysis of major complications in 693 patients].
    Wang XH; Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Liu FY
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):945-9. PubMed ID: 23336384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative safety and effectiveness of ultrasound-guided radiofrequency ablation combined with preoperative three-dimensional reconstruction versus surgical resection for solitary hepatocellular carcinoma of 3-5 cm.
    Gong Y; Tang Y; Geng Y; Zhou Y; Yu M; Huang B; Sun Z; Tang H; Jian Z; Hou B
    J Cancer; 2019; 10(22):5568-5574. PubMed ID: 31632501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
    Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
    J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.